Lisanti Capital Growth, LLC Harmony Biosciences Holdings, Inc. Transaction History

Lisanti Capital Growth, LLC

  • $344 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$30.5 - $37.4 $1.67 Million - $2.05 Million
54,800 New
54,800 $1.93 Million
Q4 2022

Feb 03, 2023
SELL
$45.4 - $60.91 $2.46 Million - $3.3 Million
-54,240 Reduced 21.86%
193,830 $10.7 Million
Q3 2022

Nov 01, 2022
SELL
$42.06 - $55.45 $2.35 Million - $3.09 Million
-55,795 Reduced 18.36%
248,070 $11 Million
Q2 2022

Aug 03, 2022
BUY
$33.54 - $52.15 $10.2 Million - $15.8 Million
303,865 New
303,865 $14.8 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email